Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Amgen Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	6,717)	6,552)	5,893)	7,264)	7,842)
Gains (losses) on foreign currency translation	50)	496)	(135)	9)	(48)
Gains (losses) on cash flow hedges	(150)	67)	324)	(438)	(66)
Gains (losses) on available-for-sale securities	—)	—)	(1)	(21)	360)
Other	42)	2)	1)	(7)	(5)
Other comprehensive income (loss), net of taxes	(58)	565)	189)	(457)	241)
Comprehensive income	6,659)	7,117)	6,082)	6,807)	8,083)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Download chart

Comprehensive income item	Description	The company
Net income	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Amgen Inc. net income increased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	Amgen Inc. comprehensive income increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.

Amgen Inc. (NASDAQ:AMGN)

Statement of Comprehensive Income